News
Accurate monitoring of CD4+ T cell counts is vital for evaluating immune health and guiding treatment in people living with ...
Researchers developed a highly sensitive MXene nanosheet biosensor for vitamin D, providing an accessible diagnostic tool for ...
THIRUVANANTHAPURAM: What if a simple drop of saliva could foretell the risk of a stroke, the early onset of diabetes, or even mouth cancer? For Haritha George, ...
NutriSen, a TUM spin-off, is revolutionizing agriculture with its smart fertilization technology, which provides precise and data-driven fertiliz ...
4d
AZoSensors on MSNNew Microfluidic Biosensor Enables Rapid, On-Site Monitoring of CD4+ T Cells for HIV CareCombining microfluidics and electrochemical sensing, this biosensor improves CD4+ T cell detection, promoting accessible HIV diagnostics in remote locations.
The Blood In situ Tracking (SENSBIT) system remained fully functional for up to a week when implanted directly into the blood ...
The new device from NIT Rourkela could make early breast cancer detection easier and more affordable, especially in remote ...
The global wearable medical device industry size is likely to generate sales amounting to USD 38.5 billion in 2024. Over the ...
Researchers at the National Institute of Technology (NIT), Rourkela, have developed an innovative semiconductor device-based ...
ROURKELA: In what could revolutionise early breast cancer detection for effective and timely cancer management, researchers ...
The device ‘TFET’ (Tunnel Field Effect Transistor) is based on TCAD (Technology Computer-Aided Design) simulation results, ...
Researchers at NIT Rourkela have developed an innovative, semiconductor-based biosensor for early breast cancer detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results